The FDA banned the sale and use of e-cigarettes on Friday.
Less than a day after the health agency told the company that it had to pull its products from the U.S. market, it received a request. There was insufficient or conflicting data about the risks of using the company's products.
Juul said in a statement that it gave enough research and evidence to address the issues raised by the agency. The company's chief regulatory officer, Joe Murillo, said in a statement on Thursday that Juul is exploring its options.
Juul requested an emergency administrative stay until it can file a motion for a stay pending review. The company and retailers would be able to distribute and sell the products until the court reviews the decision.
The company said in the filing that it was the only hope for relief that would allow it to continue selling its products.
The FDA treated Juul differently than other e-cig makers. The agency's press release announcing its ruling on Juul products was "more strident and threatening" than previous denials.
Juul said that an immediate administrative stay is critical to protect the company, its commercial partners, and its customers.
The company called out the agency for imposing immediate enforcement, instead of instating a transition period, which is typical if the product poses an immediate risk to consumers.
The FDA wouldn't say anything.